(Q33726211)

28 July 2017

1 reference

title

Diagnosis and treatment of patients with testicular germ cell cancer (English)

1 reference

testicular germ cell tumor

28 July 2017

main subject

1 reference

Hartmann JT

1

1 reference

28 July 2017

Kanz L

series ordinal

2

1 reference

28 July 2017

Bokemeyer C

series ordinal

3

1 reference

28 July 2017

publication date

1 August 1999

1 reference

28 July 2017

1 reference

28 July 2017

volume

58

1 reference

28 July 2017

issue

2

1 reference

28 July 2017

page(s)

257-281

1 reference

Filgrastim during combination chemotherapy of patients with poor-prognosis metastatic germ cell malignancy. European Organization for Research and Treatment of Cancer, Genito-Urinary Group, and the Medical Research Council Testicular Cancer Working

28 July 2017

cites work

1 reference

12 December 2020

Report on the international workshop on staging and treatment of testicular cancer

1 reference

12 December 2020

Stage I nonseminomatous germ-cell testicular cancer--management options and risk-benefit considerations.

1 reference

12 December 2020

Preliminary results of a phase I/II trial of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer.

1 reference

12 December 2020

Long-term follow-up of a phase III study of three versus four cycles of bleomycin, etoposide, and cisplatin in favorable-prognosis germ-cell tumors: the Indian University experience

1 reference

12 December 2020

The prevalence of familial testicular cancer: an analysis of two patient populations and a review of the literature

1 reference

12 December 2020

Long-Term Outcome of Patients with Relapsed and Refractory Germ Cell Tumors Treated with High-Dose Chemotherapy and Autologous Bone Marrow Rescue

1 reference

12 December 2020

High-dose carboplatin and etoposide for salvage chemotherapy of germ cell tumours

1 reference

12 December 2020

International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group

1 reference

12 December 2020

The role of paclitaxel in chemosensitive urological malignancies: current strategies in bladder cancer and testicular germ-cell tumors

1 reference

12 December 2020

Intensive induction-sequential chemotherapy with BOP/VIP-B compared with treatment with BEP/EP for poor-prognosis metastatic nonseminomatous germ cell tumor: a Randomized Medical Research Council/European Organization for Research and Treatment of C

1 reference

12 December 2020

The long‐term outcome of patients who relapse after chemotherapy for non‐seminomatous germ cell tumours

1 reference

12 December 2020

Orchidectomy alone in testicular stage I non-seminomatous germ-cell tumours

1 reference

12 December 2020

High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variables

1 reference

12 December 2020

Salvage therapy in recurrent germ cell cancer: ifosfamide and cisplatin plus either vinblastine or etoposide

1 reference

12 December 2020

Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: a Southeastern Cancer Study Group and Southwest Oncology Group protocol

1 reference

12 December 2020

Validity of predictions of residual retroperitoneal mass histology in nonseminomatous testicular cancer

1 reference

12 December 2020

High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. The German Testicular Cancer Cooperative Study Group

1 reference

12 December 2020

Radiotherapy in stage IIA and IIB testicular seminoma with reduced portals: a prospective multicenter study

1 reference

12 December 2020

Hypomagnesemia, renal dysfunction, and Raynaud's phenomenon in patients treated with cisplatin, vinblastine, and bleomycin

1 reference

12 December 2020

Dose-intensive chemotherapy in refractory germ cell cancer--a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation.

1 reference

12 December 2020

Carcinoma in situ of testicular tissue adjacent to malignant germ-cell tumors: a study of 105 cases

1 reference

12 December 2020

Importance of bleomycin in combination chemotherapy for good-prognosis testicular nonseminoma: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group

1 reference

12 December 2020

Importance of bleomycin in favorable-prognosis disseminated germ cell tumors: an Eastern Cooperative Oncology Group trial

1 reference

12 December 2020

Gemcitabine in patients with relapsed or cisplatin-refractory testicular cancer

1 reference

12 December 2020

The role of ifosfamide in testicular cancer

1 reference

12 December 2020

Placental alkaline phosphatase immunoreactivity in testicular germ-cell neoplasms

1 reference

12 December 2020

Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor

1 reference

12 December 2020

Late relapse of testicular cancer

1 reference

12 December 2020

Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups

1 reference

12 December 2020

Surgery for a post-chemotherapy residual mass in seminoma

1 reference

12 December 2020

Advanced seminoma: treatment results, survival, and prognostic factors in 142 patients

1 reference

12 December 2020

The activity of single-agent carboplatin in advanced seminoma

1 reference

12 December 2020

Comparison of histological results from the resection of residual masses at different sites after chemotherapy for metastatic non-seminomatous germ cell tumours

1 reference

12 December 2020

The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumors

1 reference

12 December 2020

Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer

1 reference

12 December 2020

Phase II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors

1 reference

12 December 2020

Surgical resection of solitary metastases after chemotherapy in patients with nonseminomatous germ cell tumors and elevated serum tumor markers

1 reference

12 December 2020

Sequences of taxol and cisplatin: a phase I and pharmacologic study

1 reference

12 December 2020

Outcome analysis for patients with persistent nonteratomatous germ cell tumor in postchemotherapy retroperitoneal lymph node dissections

1 reference

12 December 2020

Prognosis after resection of residual masses following chemotherapy for metastatic nonseminomatous testicular cancer: a multivariate analysis

1 reference

12 December 2020

Epidemiology of testicular cancer

1 reference

12 December 2020

Seminoma of the testis: a 22-year experience with radiation therapy

1 reference

12 December 2020

A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors

1 reference

12 December 2020

A randomized trial of cisplatin, vinblastine, and bleomycin versus vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis: a Southwest Oncology Group study

1 reference

12 December 2020

A randomized trial of cisplatin, etoposide and bleomycin (PEB) versus carboplatin, etoposide and bleomycin (CEB) for patients with 'good-risk' metastatic non-seminomatous germ cell tumors

1 reference

12 December 2020

The treatment of advanced testicular carcinoma with high dose chemotherapy and autologous marrow support

1 reference

12 December 2020

Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone

1 reference

12 December 2020

Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors

1 reference

12 December 2020

Simultaneous retroperitoneal, thoracic, and cervical resection of postchemotherapy residual masses in patients with metastatic nonseminomatous germ cell tumors of the testis

1 reference

12 December 2020

Gonadal dysfunction in patients treated for metastatic germ-cell tumors

1 reference

12 December 2020

Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: a Medical Research Council report

1 reference

12 December 2020

Carcinoma in situ in testicular biopsies from men presenting with infertility

1 reference

12 December 2020

Acute nonlymphocytic leukemia in germ cell tumor patients treated with etoposide-containing chemotherapy

1 reference

12 December 2020

Sequential resection of residual abdominal and thoracic masses after chemotherapy for metastatic non-seminomatous germ cell tumours

1 reference

12 December 2020

Long-term follow-up of cardiovascular risk factors in patients given chemotherapy for disseminated nonseminomatous testicular cancer

1 reference

12 December 2020

Phase II study of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer

1 reference

12 December 2020

Stage I testicular seminoma: rationale for postorchiectomy radiation therapy

1 reference

12 December 2020

The Importance of One-Stage Median Sternotomy and Retroperitoneal Node Dissection in Disseminated Testicular Cancer

1 reference

12 December 2020

A phase II trial of paclitaxel in refractory germ cell tumors

1 reference

12 December 2020

Four cycles of BEP versus an alternating regime of PVB and BEP in patients with poor-prognosis metastatic testicular non-seminoma; a randomised study of the EORTC Genitourinary Tract Cancer Cooperative Group

1 reference

12 December 2020

Predictors of residual mass histology following chemotherapy for metastatic non-seminomatous testicular cancer: a quantitative overview of 996 resections

1 reference

12 December 2020

Prognostic factors for favorable outcome in disseminated germ cell tumors

1 reference

12 December 2020

Testicular cancer in cryptorchids

1 reference

12 December 2020

Phase II trial of paclitaxel shows antitumor activity in patients with previously treated germ cell tumors

1 reference

12 December 2020

Risk of Second Malignant Neoplasms Among Long-term Survivors of Testicular Cancer

1 reference

12 December 2020

Surgical resection in disseminated testicular cancer following chemotherapeutic cytoreduction

1 reference

12 December 2020

High-dose VP-16-213 monotherapy for refractory germinal malignancies: a phase II study

1 reference

12 December 2020

Secondary Raynaud's phenomenon and other late vascular complications following chemotherapy for testicular cancer

1 reference

12 December 2020

Endocrinological late effects after chemotherapy for testicular cancer

1 reference

12 December 2020

Changing incidence and delay of testicular cancer in southern Norway (1981-1992)

1 reference

12 December 2020

Silibinin protects against cisplatin-induced nephrotoxicity without compromising cisplatin or ifosfamide anti-tumour activity

1 reference

12 December 2020

Sequential excision of residual thoracic and retroperitoneal masses after chemotherapy for stage III germ cell tumors

1 reference

12 December 2020

Dose escalation study of high-dose carboplatin and etoposide with autologous bone marrow support in patients with recurrent and refractory germ cell tumors.

1 reference

12 December 2020

Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide

1 reference

12 December 2020

Staging relationships and outcome in early stage testicular cancer: a report from the Testicular Cancer Intergroup Study

1 reference

12 December 2020

Postchemotherapy resections of residual masses from metastatic non-seminomatous testicular germ cell tumors

1 reference

12 December 2020

Post-chemotherapy surgery in advanced non-seminomatous germ-cell testicular tumours: the significance of histology with particular reference to differentiated (mature) teratoma

1 reference

12 December 2020

An excess of testicular germ cell tumors in Down's syndrome: three case reports and a review of the literature

1 reference

12 December 2020

Tumor classification and size in germ-cell testicular cancer: influence on the occurrence of metastases

1 reference

12 December 2020

Salvage treatment in male patients with germ cell tumours

1 reference

12 December 2020

Post-chemotherapy lymph node histology in radiologically normal patients with metastatic nonseminomatous testicular cancer

1 reference

12 December 2020

Successful treatment of resistant germinal neoplasms with VP-16 and cisplatin: results of a Southeastern Cancer Study Group trial.

1 reference

12 December 2020

Early intensified chemotherapy with autologous bone marrow transplantation in first line treatment of poor risk non-seminomatous germ cell tumours. Preliminary results of a French randomized trial

1 reference

12 December 2020

Sarcoma arising in a residual testicular teratoma after cytoreductive chemotherapy

1 reference

12 December 2020

Increased plasma renin and aldosterone in patients treated with cisplatin-based chemotherapy for metastatic germ-cell tumors

1 reference

12 December 2020

Prediction of long-term response after high-dose chemotherapy with autologous bone marrow transplantation in the salvage treatment of non-seminomatous germ cell tumours

1 reference

12 December 2020

Evaluation of long-term toxicity after chemotherapy for testicular cancer

1 reference

12 December 2020

Salvage chemotherapy for recurrent germ cell cancer

1 reference

12 December 2020

Fertility after chemotherapy for testicular germ cell cancers

1 reference

12 December 2020

Positron emission tomography evaluation of residual radiographic abnormalities in postchemotherapy germ cell tumor patients

1 reference

12 December 2020

Etoposide and cisplatin adjuvant therapy for patients with pathologic stage II germ cell tumors

1 reference

12 December 2020

Treatment of germ cell cancer with two cycles of high-dose ifosfamide, carboplatin, and etoposide with autologous stem-cell support

1 reference

12 December 2020

Treatment options in clinical stage I non-seminomatous germ cell tumours of the testis: a wager on the future? A review

1 reference

12 December 2020

MIB-1 immunohistochemistry in clinical stage I nonseminomatous testicular germ cell tumors predicts patients at low risk for metastasis

1 reference

12 December 2020

Cytogenetics of carcinoma in situ of the testis

1 reference

12 December 2020

Histology and DNA contents of a secondary malignancy arising in a mature residual lesion six years after chemotherapy for a disseminated nonseminomatous testicular tumor

1 reference

12 December 2020

Cisplatin combination chemotherapy in advanced seminoma

1 reference

12 December 2020

High-dose carboplatin, etoposide, and cyclophosphamide for patients with refractory germ cell tumors: treatment results and prognostic factors for survival and toxicity.

1 reference

12 December 2020

Cytogenetics of male germ-cell tumors

1 reference

12 December 2020

Secondary neoplasms following treatment of malignant germ cell tumors

1 reference

12 December 2020

Management of residual mass in advanced seminoma: results and recommendations from the Memorial Sloan-Kettering Cancer Center

1 reference

12 December 2020

Risk of secondary myeloid leukemia and myelodysplastic syndrome following standard-dose chemotherapy or high-dose chemotherapy with stem cell support in patients with potentially curable malignancies

1 reference

12 December 2020

Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection

1 reference

12 December 2020

Platinum organ toxicity and possible prevention in patients with testicular cancer

1 reference

12 December 2020

Role of etoposide-based chemotherapy in the treatment of patients with refractory or relapsing germ cell tumors

1 reference

12 December 2020

High-dose chemotherapy supported with autologous bone marrow transplantation (ABMT) in germ cell tumors: a phase two study

1 reference

12 December 2020

Hematopoietic growth factors and treatment of testicular cancer: biological interactions, routine use and dose-intensive chemotherapy

1 reference

12 December 2020

Raynaud's Phenomenon: A Common Toxicity After Combination Chemotherapy for Testicular Cancer

1 reference

12 December 2020

Prevalence of contralateral testicular intraepithelial neoplasia in patients with testicular germ cell neoplasms.

1 reference

12 December 2020

Cisplatin and etoposide salvage therapy and resection of the residual tumor in pretreated germ cell testicular cancer

1 reference

12 December 2020

Results of radiotherapy for stage II testicular seminoma

1 reference

12 December 2020

Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study

1 reference

12 December 2020

The growing teratoma syndrome

1 reference

12 December 2020

Primary retroperitoneal lymph node dissection in clinical stage A non-seminomatous germ cell testis cancer. Review of the Indiana University experience 1965-1989.

1 reference

12 December 2020

Treatment of clinical stage I testicular cancer and a possible role for new biological prognostic parameters

1 reference

12 December 2020

Long-term effects on sexual function and fertility after treatment of testicular cancer

1 reference

12 December 2020

Identification of clinical stage A nonseminomatous testis cancer patients at extremely low risk for metastatic disease: a combined approach using quantitive immunohistochemical, histopathologic, and radiologic assessment

1 reference

12 December 2020

Lack of late toxicity in patients treated with cisplatin-containing combination chemotherapy for metastatic testicular cancer.

1 reference

12 December 2020

Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours

1 reference

12 December 2020

Distribution of nodal metastases in nonseminomatous testis cancer

1 reference

12 December 2020

Treatment of the Residual Retroperitoneal Mass After Chemotherapy for Advanced Seminoma

1 reference

12 December 2020

The importance of prognostic factors in the individual treatment of patients with disseminated germ cell tumours

1 reference

12 December 2020

Four cycles of BEP vs four cycles of VIP in patients with intermediate-prognosis metastatic testicular non-seminoma: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group. European Organization for Research and Treatment of Ca

1 reference

12 December 2020

Diverging trends in incidence and mortality of testicular cancer in Denmark, 1943-1982.

1 reference

12 December 2020

Chemotherapy with maximally tolerable doses of VP 16-213 and cyclophosphamide followed by autologous bone marrow transplantation for the treatment of relapsed or refractory germ cell tumors.

1 reference

12 December 2020

Persistent cancer in postchemotherapy retroperitoneal lymph-node dissection: outcome analysis.

1 reference

12 December 2020

Residual mass following chemotherapy of seminoma

1 reference

12 December 2020

Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide in treatment of advanced disseminated germ cell tumors: an Eastern Cooperative Oncology Group, Southwest Oncology Group, and Cancer and Leukemia Group B Study

1 reference

12 December 2020

Ifosfamide- and cisplatin-containing chemotherapy as first-line salvage therapy in germ cell tumors: response and survival

1 reference

12 December 2020

The treatment of advanced metastatic seminoma: experience in 55 cases

1 reference

12 December 2020

Long-term effects of chemotherapy in patients with testicular cancer

1 reference

12 December 2020

Para-aortic lymphadenectomy after chemotherapy for metastatic non-seminomatous germ cell tumours: prognostic value and therapeutic benefit

1 reference

12 December 2020

Cyclophosphamide and sequential cisplatin for advanced seminoma: long-term followup in 52 patients

1 reference

12 December 2020

A randomized trial of standard chemotherapy v a high-dose chemotherapy regimen in the treatment of poor prognosis nonseminomatous germ-cell tumors.

1 reference

12 December 2020

Radiotherapy for testicular seminoma stage I: treatment results and long-term post-irradiation morbidity in 365 patients

1 reference

12 December 2020

Comparison of the antitumor activity of cisplatin, carboplatin, and iproplatin against established human testicular cancer cell lines in vivo and in vitro

1 reference

12 December 2020

Long-term complications of cisplatin-based chemotherapy for testis cancer.

1 reference

12 December 2020

Surgical salvage of chemorefractory germ cell tumors

1 reference

12 December 2020

Treatment of advanced seminoma with cyclophosphamide, vincristine and carboplatin on an outpatient basis

1 reference

12 December 2020

Pre-clinical activity of taxol in non-seminomatous germ cell tumor cell lines and nude mouse xenografts

1 reference

12 December 2020

Long-term survival of patients with recurrent or refractory germ cell tumors after high dose chemotherapy.

1 reference

12 December 2020

Radiotherapy after chemotherapy for metastatic seminoma--a diminishing role. MRC Testicular Tumour Working Party

1 reference

12 December 2020

Risk of secondary leukemia following high cumulative doses of etoposide during chemotherapy for testicular cancer

1 reference

12 December 2020

Treatment of testicular cancer and the development of secondary malignancies

1 reference

12 December 2020

Trebling of the incidence of testicular cancer in victoria, Australia (1950-1985).

1 reference

12 December 2020

Dexamethasone, granisetron, or both for the prevention of nausea and vomiting during chemotherapy for cancer

1 reference

12 December 2020

Prognosis after salvage treatment for unselected male patients with germ cell tumours

1 reference

12 December 2020

Outcome analysis after post-chemotherapy surgery in patients with non-seminomatous germ cell tumours

1 reference

12 December 2020

High-dose chemotherapy and autologous bone marrow rescue for patients with refractory germ cell tumors. Early intervention is better tolerated

1 reference

12 December 2020

Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Resear

1 reference

12 December 2020

Chemotherapy of metastatic seminoma: the Southeastern Cancer Study Group experience

1 reference

12 December 2020

Cytogenetic analysis of 124 prospectively ascertained male germ cell tumors

1 reference

12 December 2020

Second cancer risk following testicular cancer: a follow-up study of 1,909 patients.

1 reference

12 December 2020

Secondary leukemia associated with a conventional dose of etoposide: review of serial germ cell tumor protocols

1 reference

12 December 2020

Flow cytometric and cytophotometric DNA analysis cannot predict subsequent tumour recurrence in pathological stage IIA/B non-seminomatous testicular germ cell tumour patients who do not receive adjuvant chemotherapy

1 reference

12 December 2020

Post-chemotherapy tumor residuals in patients with advanced nonseminomatous testicular cancer. Is it necessary to resect all residual masses?

1 reference

12 December 2020

The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group.

1 reference

12 December 2020

Cisplatin and ifosfamide with either vinblastine or etoposide as salvage therapy for refractory or relapsing germ cell tumor patients: the Institut Gustave Roussy experience

1 reference

12 December 2020

Nerve sparing post-chemotherapy retroperitoneal lymph node dissection for advanced testicular cancer

1 reference

12 December 2020

Nerve-sparing retroperitoneal lymphadenectomy with preservation of ejaculation

1 reference

12 December 2020

Cisplatin, etoposide, and ifosfamide salvage therapy for refractory or relapsing germ cell carcinoma

1 reference

12 December 2020

Toxicity of treatment of germ cell tumors

1 reference

12 December 2020

Long-term follow-up of patients with good-risk germ cell tumors treated with etoposide and cisplatin

1 reference

12 December 2020

Prognosis and other clinical correlates of pathologic review in stage I and II testicular carcinoma: a report from the Testicular Cancer Intergroup Study

1 reference

12 December 2020

Clinical relevance of the i(12p) marker chromosome in germ cell tumors

1 reference

12 December 2020

Single-agent carboplatinum for advanced seminoma. A phase II study

1 reference

12 December 2020

Comparative genomic hybridization of germ cell tumors of the adult testis: confirmation of karyotypic findings and identification of a 12p-amplicon

1 reference

12 December 2020

Multivariate analysis of prognostic variables in patients with metastatic testicular cancer.

1 reference

12 December 2020

Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer

1 reference

12 December 2020

Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms

1 reference

12 December 2020

Cisplatin, vincristine and ifosphamide combination chemotherapy of metastatic seminoma: results of EORTC trial 30874. EORTC GU Group

1 reference

12 December 2020

Adjuvant chemotherapy for high-risk clinical stage I nonseminomatous testicular germ cell cancer: long-term results of a prospective trial

1 reference

12 December 2020

10.2165/00003495-199958020-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

28 July 2017

1053168803

0 references

Fatcat ID

release_y2quicp23veo3mptkbtscqrvf4

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/y2quicp23veo3mptkbtscqrvf4

24 November 2022

mapped directly with Wikidata item

1 reference